Chronic lymphocytic leukaemia - the role of the microenvironment pathogenesis and therapy-Reference-Cited by-同舟云学术

Chronic lymphocytic leukaemia - the role of the microenvironment pathogenesis and therapy

Published:2013-04-25 Issue:1 Volume:162 Page:15-24
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Ramsay Alan D.¹,Rodriguez-Justo Manuel¹

Affiliation:

1. Department of Cellular Pathology; University College Hospital London; London; UK

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12344/fullpdf

Reference105 articles.

1. B-cell antigen receptor activates transcription factors NFAT (nuclear factor of activated T-cells) and NF-kappaB (nuclear factor kappaB) via a mechanism that involves diacylglycerol;Antony;Biochemical Society Transactions,2004

2. Expression of adhesion molecules on leukemic B cells from chronic lymphocytic leukemia patients with predominantly splenic manifestations;Bairey;Israeli Medical Association Journal,2004

3. Is NF-kB a good target for cancer therapy? Hopes and pitfalls;Baud;Nature Reviews Drug Discovery,2009

4. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment;Bernhagen;Nature Medicine,2007

5. CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease;Borghese;Expert Opinion on Therapeutic Targets,2011

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia;International Journal of Molecular Sciences;2022-06-16

2. A novel triple-action inhibitor targeting B-cell receptor signaling and BRD4 demonstrates preclinical activity in chronic lymphocytic leukemia;2022-05-11

3. Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner;Oncogene;2019-11-26

4. SLAMF receptors on normal and malignant B cells;Clinical Immunology;2019-07

5. Immunomodulation in leukemia: cellular aspects of anti-leukemic properties;Clinical and Translational Oncology;2019-05-24